The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases
Open accessAbstract
BACKGROUND.: The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology. METHODS.: A total of 105 consecutive patients treated preoperatively with 5FU/OX chemotherapy with (n = 62) or without (n = 43) bevacizumab were analyzed. The response to chemotherapy was evaluated by pathologic analysis of tumor viability (percentage of viable tumor in relation to tumor surface area). The incidence and grade of hepatic sinusoidal dilation were also investigated. RESULTS.: Bevacizumab‐containing regimens significantly reduced the degree of tumor viability compared with 5FU/OX‐only chemotherapy (32.9% vs 45.3%; P = .02). After stratification according to the magnitude of tumor viability, a higher proportion of patients treated with bevacizumab than without had <25% residual viable tumor cells (45% vs 23%; P = .02). However, the addition of bevacizumab to 5FU/OX did not appear to increase the incidence of complete pathologic response (11.3% vs 11.6%; P = .59). The incidence and severity of sinusoidal dilation was lower in patients treated with bevacizumab than in those treated with 5FU/OX only (any grade: 27.4% vs 53.5%; moderate or severe: 8.1% vs 27.9%; both P < .01). CONCLUSIONS.: In patients treated with 5FU/OX chemotherapy, bevacizumab improves the pathologic response, as demonstrated by a reduction of the degree of tumor viability, and reduces the incidence and severity of hepatic injury. This retrospective study provides additional evidence supporting the use of bevacizumab in combination with 5FU/OX for CLM. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6305 · Cited by 2,279
Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., Giacchetti, S., Paule, B., Kunstlinger, F., Ghémard, O., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141198.92114.f6 · Cited by 1,480
Vauthey, J.-N., Pawlik, T. M., Ribero, D., Wu, T.-T., Zorzi, D., Hoff, P. M., Xiong, H. Q., Eng, C., Lauwers, G. Y., Mino-Kenudson, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3074 · Cited by 1,300
Self-citationMcDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Rubbia-Brandt, L., Audard, V., Sartoretti, P., Roth, A. D., Brezault, C., Le Charpentier, M., Dousset, B., Morel, P., Soubrane, O., Chaussade, S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh095 · Cited by 1,038
Adam, R., Pascal, G., Castaing, D., Azoulay, D., Delvart, V., Paule, B., Levi, F., & Bismuth, H. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000145964.08365.01 · Cited by 1,001
Karoui, M., Penna, C., Amin-Hashem, M., Mitry, E., Benoist, S., Franc, B., Rougier, P., & Nordlinger, B. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000193603.26265.c3 · Cited by 721
Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)
DeLeve, L. D., Shulman, H. M., & McDonald, G. B. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-23204 · Cited by 664
Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?
Benoist, S., Brouquet, A., Penna, C., Julié, C., El Hajjam, M., Chagnon, S., Mitry, E., Rougier, P., & Nordlinger, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8727 · Cited by 607
Alberts, S. R., Horvath, W. L., Sternfeld, W. C., Goldberg, R. M., Mahoney, M. R., Dakhil, S. R., Levitt, R., Rowland, K., Nair, S., Sargent, D. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.740 · Cited by 537
Rubbia-Brandt, L., Giostra, E., Brezault, C., Roth, A. D., Andres, A., Audard, V., Sartoretti, P., Dousset, B., Majno, P. E., Soubrane, O., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl386 · Cited by 523
Aloia, T., Sebagh, M., Plasse, M., Karam, V., Lévi, F., Giacchetti, S., Azoulay, D., Bismuth, H., Castaing, D., & Adam, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8156 · Cited by 515
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
Laurent, A., Nicco, C., Chéreau, C., Goulvestre, C., Alexandre, J., Alves, A., Lévy, E., Goldwasser, F., Panis, Y., Soubrane, O., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.948.65.3 · Cited by 509
Carreras, E., Bertz, H., Arcese, W., Vernant, J., Tomás, J.-F., Hägglund, H., Bandini, G., Espérou, H., Russell, J., de la Rubia, J., et al. (1998) · PubMed · doi:10.1182/blood.v92.10.3599 · Cited by 343
Allen, P. J., Kemeny, N., Jarnagin, W., DeMatteo, R., Blumgart, L., & Fong, Y. (2003) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(02)00121-x · Cited by 301
Bouzourene, H., Bosman, F. T., Seelentag, W., Matter, M., & Coucke, P. (2002) · Cancer · doi:10.1002/cncr.10327 · Cited by 285
Ajani, J. A., Mansfield, P. F., Crane, C. H., Wu, T. T., Lunagomez, S., Lynch, P. M., Janjan, N., Feig, B., Faust, J., Yao, J. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.305 · Cited by 282
SENECIO DISEASE, OR CIRRHOSIS OF THE LIVER DUE TO SENECIO POISONING.
Willmot, F., & Robertson, G. (1920) · The Lancet · doi:10.1016/s0140-6736(01)00020-4 · Cited by 201
Alexandre, J., Nicco, C., Chéreau, C., Laurent, A., Weill, B., Goldwasser, F., & Batteux, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj049 · Cited by 199
Surgical Resection After Downsizing of Colorectal Liver Metastasis in the Era of Bevacizumab
Ellis, L. M., Curley, S. A., & Grothey, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.754 · Cited by 163
Self-citationDeLeve, L. D., Wang, X., Tsai, J., Kanel, G. C., Strasberg, S. M., & Tökés, Z. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01056-4 · Cited by 144
Hochster, H. S., Hart, L. L., Ramanathan, R. K., Hainsworth, J. D., Hedrick, E. E., & Childs, B. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.3510 · Cited by 135
Wang, X., Kanel, G. C., & DeLeve, L. D. (2000) · Hepatology · doi:10.1002/hep.510310224 · Cited by 130
Hasegawa, S., Horibe, K., Kawabe, T., Kato, K., Kojima, S., Matsuyama, T., & Hirabayashi, N. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701506 · Cited by 95
Bechtold, R. E., Chen, M. Y. M., Stanton, C. A., Savage, P. D., & Levine, E. A. (2003) · Abdominal Imaging · doi:10.1007/s00261-003-0021-2 · Cited by 73
Downstaging or Downsizing: Time for a New Staging System in Advanced Colorectal Cancer?
Poston, G. J., Adam, R. A., & Vauthey, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8404 · Cited by 47
Self-citationMalaisrie, S. C., Hofstetter, W. L., Correa, A. M., Ajani, J. A., Komaki, R. R., Rice, D. C., Vaporciyan, A. A., Walsh, G. L., Roth, J. A., Wu, T. T., et al. (2006) · Cancer · doi:10.1002/cncr.22077 · Cited by 37
Cited by
Adam, R., de Gramont, A., Figueras, J., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., Sobrero, A., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.06.006 · Cited by 607
Self-citationBlazer, D. G., Kishi, Y., Maru, D. M., Kopetz, S., Chun, Y. S., Overman, M. J., Fogelman, D., Eng, C., Chang, D. Z., Wang, H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5299 · Cited by 604
Self-citationAdam, R., De Gramont, A., Figueras, J., Guthrie, A., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0121 · Cited by 583
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
Frentzas, S., Simoneau, E., Bridgeman, V. L., Vermeulen, P. B., Foo, S., Kostaras, E., Nathan, M. R., Wotherspoon, A., Gao, Z.-H., Shi, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4197 · Cited by 454
Metadata
- Authors
- Ribero, D., Wang, H., Donadon, M., Zorzi, D., Thomas, M. B., Eng, C., Chang, D. Z., Curley, S. A., Abdalla, E. K., Ellis, L. M., & Vauthey, J.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-10-24
- Volume
- 110
- Issue
- 12
- Pages
- 2761-2767
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1974913186
- Cited by
- 375
- References
- 29
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.